Abstract: BACKGROUND: Gabapentinoid use for long-term cancer pain control may be problematic, given unclear mechanisms of action and increased concerns for physical dependence. The purpose of this report is to examine trends of gabapentinoid use among [...]
AAPM Member and MedPage Today Pain Points blog contributor Heath McAnally, MD, discusses that the overzealous attention to gabapentinoids and its potential for non-indicated prescription, misuse, abuse and adverse effects. "We're in a war against [...]
Abstract: OBJECTIVE: To examine associations between gabapentinoids and adverse outcomes related to coordination disturbances (head or body injuries, or both and road traffic incidents or offences), mental health (suicidal behaviour, unintentional overdoses), and criminality.Read the [...]
The gabapentinoid drugs gabapentin and pregabalin were originally developed as antiseizure drugs but now are prescribed mainly for treatment of pain. For gabapentin, the only pain-related indication approved by the US Food and Drug Administration [...]
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources
American Academy of Pain Medicine (AAPM) is a nonprofit 501(c)(6) tax-exempt organization.
